Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Hayette · SciRah

Researcher profile · Semantic Scholar

S. Hayette

Share profile

S. Hayette — researcher profile on SciRah

h-index: 37
Works: 191
Citations: 4,882

Most-cited papers

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
Y. Chalandon, X. Thomas, S. Hayette, J. Cayuela +16 more
2015Blood343 citations Open access
Semantic Scholar
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
P. Rousselot, M. Coudé, N. Gokbuget, Carlo Gambacorti Passerini +32 more
2016Blood293 citations Open access
Semantic Scholar
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.
M. Balsat, Aline Renneville, X. Thomas, S. de Botton +19 more
2017Journal of Clinical Oncology248 citations
Semantic Scholar
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study.
A. Tanguy-Schmidt, P. Rousselot, Y. Chalandon, J. Cayuela +11 more
2013Biology of Blood and Marrow Transplantation141 citations Open access
Semantic Scholar
A gene-expression profiling score for outcome prediction disease in patients with follicular lymphoma: a retrospective analysis on three international cohorts
S. Huet, B. Tesson, J. Jais, A. Feldman +26 more
2018The Lancet Oncology134 citations Open access
Semantic Scholar
A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
H. White, L. Deprez, P. Corbisier, V. Hall +67 more
2014Leukemia80 citations Open access
Semantic Scholar
EZH2 alterations in follicular lymphoma: biological and clinical correlations
S. Huet, L. Xerri, B. Tesson, S. Mareschal +14 more
2017Blood Cancer Journal79 citations Open access
Semantic Scholar
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin
J. Lambert, J. Lambert, O. Nibourel, C. Pautas +9 more
2014OncoTarget78 citations Open access
Semantic Scholar
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
H. Pfeifer, G. Cazzaniga, V. V. D. van der Velden, J. Cayuela +35 more
2019Leukemia74 citations Open access
Semantic Scholar
Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma
L. Jallades, L. Baseggio, P. Sujobert, S. Huet +14 more
2017Haematologica64 citations Open access
Semantic Scholar
Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy
G. Étienne, S. Dulucq, F. Nicolini, S. Morisset +11 more
2014Haematologica63 citations Open access
Semantic Scholar
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
Aline Renneville, R. B. Abdelali, S. Chevret, O. Nibourel +13 more
2014OncoTarget53 citations Open access
Semantic Scholar
Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.
F. Nicolini, G. Étienne, V. Dubruille, L. Roy +19 more
2015The Lancet Haematology49 citations
Semantic Scholar
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 Study
R. Kim, Y. Chalandon, P. Rousselot, J. Cayuela +30 more
2024Journal of Clinical Oncology40 citations Open access
Semantic Scholar
Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients
V. Marcel, Frédéric Catez, C. Berger, Emeline Perrial +8 more
2017PLoS ONE39 citations Open access
Semantic Scholar
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
H. White, Matthew Salmon, F. Albano, C. Andersen +57 more
2022Leukemia36 citations Open access
Semantic Scholar
High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia
A. Plesa, C. Dumontet, Eve Mattei, Ines Tagoug +18 more
2017World Journal of Stem Cells35 citations Open access
Semantic Scholar
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies
A. Traverse-Glehen, A. Verney, S. Gazzo, L. Jallades +9 more
2017Leukemia and Lymphoma29 citations
Semantic Scholar
Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended
S. Huet, P. Cony-Makhoul, M. Heiblig, I. Tigaud +7 more
2014PLoS ONE28 citations Open access
Semantic Scholar
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
J. Lambert, J. Lambert, X. Thomas, A. Marceau-Renaut +16 more
2021Blood Advances26 citations Open access
Semantic Scholar
Successful pregnancies in patients with BCR‐ABL‐positive leukemias treated with interferon‐alpha therapy during the tyrosine kinase inhibitors era
M. Balsat, Madeleine Etienne, M. Elhamri, S. Hayette +2 more
2018European Journal of Haematology23 citations
Semantic Scholar
FLT3‐TKD Mutations Associated With NPM1 Mutations Define a Favorable‐risk Group in Patients With Acute Myeloid Leukemia
M. Perry, S. Bertoli, C. Rocher, S. Hayette +7 more
2018Clinical Lymphoma, Myeloma & Leukemia22 citations
Semantic Scholar
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French Nilo post‐STIM study
S. Dulucq, F. Rigal-huguet, F. Nicolini, P. Cony-Makhoul +15 more
2023British Journal of Haematology21 citations Open access
Semantic Scholar
Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life.
S. Huet, E. Paubelle, Camille Lours, Béatrice Grange +11 more
2018Blood20 citations Open access
Semantic Scholar
Molecular characterization and follow‐up of five CML patients with new BCR–ABL1 fusion transcripts
S. Huet, S. Dulucq, A. Chauveau, A. Menard +13 more
2015Genes, Chromosomes and Cancer20 citations
Semantic Scholar
Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib
Alexis Genthon, F. Nicolini, F. Huguet, Carole Colin-Gil +10 more
2020OncoTarget19 citations Open access
Semantic Scholar
Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience
M. Heiblig, H. Labussière-Wallet, F. Nicolini, M. Michallet +11 more
2019Cancers17 citations Open access
Semantic Scholar
Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors
G. Étienne, S. Dulucq, F. Huguet, A. Schmitt +15 more
2019Cancer Medicine16 citations Open access
Semantic Scholar
Real life evaluation of AlphaMissense predictions in hematological malignancies
K. Chabane, Carole Charlot, Dan Gugenheim, T. Simonet +7 more
2023Leukemia15 citations
Semantic Scholar
Real‐life targeted next‐generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network
C. Bommier, C. Mauduit, J. Fontaine, E. Bourbon +10 more
2021British Journal of Haematology15 citations Open access
Semantic Scholar
Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on front-line imatinib.
F. Nicolini, V. Alcazer, P. Cony-Makhoul, M. Heiblig +9 more
2018Experimental Hematology14 citations Open access
Semantic Scholar
Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission
S. Dulucq, S. Hayette, J. Cayuela, F. Bauduer +13 more
2022Haematologica13 citations Open access
Semantic Scholar
Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
E. Paubelle, A. Plesa, S. Hayette, M. Elhamri +4 more
2019Oncology and Therapy12 citations Open access
Semantic Scholar
Molecular analysis of a CD19-negative diffuse large B-cell lymphoma
Lorric Delage, D. Manzoni, Charles Quinquenet, J. Fontaine +8 more
2018Haematologica12 citations Open access
Semantic Scholar
Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies
S. Hayette, Béatrice Grange, M. Vallée, C. Bardel +11 more
2021HemaSphere11 citations Open access
Semantic Scholar
Efficiency of blinatumomab in a t(8;21) acute myeloid leukemia expressing CD19
A. Plesa, H. Labussière-Wallet, S. Hayette, G. Salles +2 more
2019Haematologica11 citations Open access
Semantic Scholar
What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies
Y. Guillermin, Jonathan Lopez, K. Chabane, S. Hayette +4 more
2018International Journal of Molecular Sciences11 citations Open access
Semantic Scholar
Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature
A. Quintela, P. Sujobert, I. Tigaud, S. Hayette +4 more
2017Oncology and Therapy11 citations Open access
Semantic Scholar
The BCR-ABLT 315 I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors , in a matched pair analysis
F. Nicolini, Amr Ibrahim, S. Soverini, G. Martinelli +23 more
201311 citations
Semantic Scholar
[Recommendations from the French CML Study Group (Fi-LMC) for BCR-ABL1 kinase domain mutation analysis in chronic myeloid leukemia].
J. Cayuela, J. Chomel, V. Coiteux, S. Dulucq +8 more
2020Bulletin du Cancer9 citations Open access
Semantic Scholar
The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
Wei W. Chien, R. Catallo, Amel Chebel, L. Baranger +17 more
2015Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis8 citations
Semantic Scholar
New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia
S. Huet, L. Jallades, Carole Charlot, K. Chabane +4 more
2013Leukemia Research and Treatment8 citations Open access
Semantic Scholar
Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication
G. Antherieu, A. Bidet, S. Huet, S. Hayette +7 more
2021Cancers7 citations Open access
Semantic Scholar
Impact of NPM1 mutation subtypes on treatment outcome in AML: The Lyon-University Hospital experience.
M. Heiblig, P. Sujobert, S. Hayette, M. Balsat +3 more
2019Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis7 citations
Semantic Scholar
A novel method for room temperature distribution and conservation of RNA and DNA reference materials for guaranteeing performance of molecular diagnostics in onco-hematology: A GBMHM study.
J. Cayuela, Carole Mauté, A. Fabre, O. Nibourel +6 more
2015Clinical Biochemistry7 citations
Semantic Scholar
Clinical outcome of therapy‐related acute myeloid leukemia patients. Real‐life experience in a University Hospital and a Cancer Center in France
A. Belhabri, M. Heiblig, S. Morisset, L. Vila +18 more
2023Cancer Medicine6 citations Open access
Semantic Scholar
Impact on outcome of MRD prior hematopoietic stem cell transplantation after FLAMSA-busulfan conditioning regimen: a retrospective monocentric study.
Grégoire Le Meur, A. Plesa, M. Larcher, G. Fossard +16 more
2022Transplantation and Cellular Therapy6 citations Open access
Semantic Scholar
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry.
A. Plesa, C. Roumier, Joris Gutrin, M. Larcher +13 more
2021Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis6 citations
Semantic Scholar
Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia
S. Huet, A. Bouvard, Emmanuelle Ferrant, I. Mosnier +5 more
2020Leukemia6 citations
Semantic Scholar
Next-CLL: a new next generation sequencing-based method for assessment of IGHV gene mutational status in chronic lymphoid leukemia.
E. Bourbon, K. Chabane, I. Mosnier, A. Bouvard +7 more
2023Journal of Molecular Diagnostics5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Sujobert×20
Invite
P. Sujobert — researcher profile on SciRah
X. Thomas×19
Invite
X. Thomas — researcher profile on SciRah
G. Salles×17
Invite
G. Salles — researcher profile on SciRah
F. Nicolini×15
Invite
F. Nicolini — researcher profile on SciRah

×14

Invite

S. Huet — researcher profile on SciRah

Invite

J. Cayuela — researcher profile on SciRah

Invite

K. Chabane — researcher profile on SciRah

Invite

S. Dulucq — researcher profile on SciRah

Invite

A. Plesa — researcher profile on SciRah

Invite

I. Tigaud — researcher profile on SciRah

Invite

M. Heiblig — researcher profile on SciRah

Invite

H. Dombret — researcher profile on SciRah